Target intelligence / Profile preview

Elongin C pseudogene 5 (ELOCP5)

Target: ELOCP5
Molecular classification: Other (pseudogene)

Overview

Elongin C pseudogene 5 (ELOCP5) is a *pseudogene* related to the ELOC gene, which encodes elongin C, a regulatory subunit of the transcription factor B (SIII) complex. While elongin C participates in transcription elongation by RNA polymerase II and ubiquitin-mediated protein degradation via cullin-RING ligase complexes[4], ELOCP5 does not produce functional protein and is not an established biological or therapeutic target. Pseudogenes like ELOCP5 may sometimes produce non-coding RNAs with potential minor regulatory activity, but there is no credible literature or database evidence of functional or pathogenic roles, or drug targeting, for ELOCP5[2][3][4].

Other names: Elongin C pseudogene 5ELOCP5

Beyond the preview

Go deeper on Elongin C pseudogene 5 (ELOCP5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongin C pseudogene 5 (ELOCP5).

Explore the full profile